01.09.2014 Views

ANNUAL REVIEW master Final3a - St Vincent's University Hospital

ANNUAL REVIEW master Final3a - St Vincent's University Hospital

ANNUAL REVIEW master Final3a - St Vincent's University Hospital

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

<strong>St</strong>. Vincent’s Healthcare Group Limited - Annual Review 2007<br />

Department - Rheumatology<br />

• Chairman, Bone and Joint Accreditation committee<br />

• Medical Director, Rheumatology Rehabilitation Unit, Our Lady’s Hospice, Harold’s Cross<br />

• International Advisor to Wyeth (Global), Wyeth (Europe), Schering-Plough (Global),<br />

Centocor (Global) and GlaxoSmithKline (Global)<br />

• IJMS Awards Best Published Paper – Rheumatology 2007<br />

• Joint Irish and British Society of Rheumatology - Best Oral presentation 2007<br />

• SIAR Award - American College of Rheumatology 2007<br />

• Visiting Speaker<br />

Swiss Rheumatology Society<br />

British Society for Rheumatology<br />

<strong>University</strong> of Newcastle<br />

Grants<br />

Efficacy of switching anti-TNF therapies in patients with rheumatoid arthritis.<br />

Abbott: €64,000 (PI-Oliver FitzGerald)<br />

Etanercept in Psoriasis and Psoriatic Arthritis: A pilot study in 15 patients.<br />

Wyeth: €120,000 (PI-Oliver FitzGerald)<br />

Differential expression of VEGF, PIGF and the VEGF receptors in Inflammatory arthritis.<br />

HRB Project Grant: €165,000 (PI-Oliver FitzGerald)<br />

Differential Protein expression in psoriatic arthritis synovial tissue following<br />

anti-TNF therapy. (PI-Oliver FitzGerald)<br />

Abbott: €100,000<br />

Development of Inflammatory Arthritis database.<br />

Abbott: €240,000 (PI-Oliver FitzGerald)<br />

Hypoxia-induced mitochondrial signalling pathways in inflammatory arthritis.<br />

HRB Translational Award 2006-2011, €1.5m (PI-Douglas Veale)<br />

Autocure EU 6th Framework Grant (PI-Barry Bresnihan)<br />

‘Curing Autoimmune Disease – translational approach’ €212,500 over 5 years<br />

Biopharmaceutical/Pharmaceutical Science Programme<br />

PRTLI Cycle 4, €4.6 million (Co-applicant – Douglas Veale)<br />

A CELLMAX® Artificial Capillary System and Flexercell <strong>St</strong>rain Unit<br />

UCD Research Support Schemes. €35k (PI - Douglas Veale)<br />

Hypoxia-induced mitochondrial signaling pathways in inflammatory arthritis promote<br />

angiogenesis and synovial invasiveness and may predict response to therapy.<br />

HRB Translational Award €1.4 million (PI - Douglas Veale)<br />

Return to Contents<br />

215

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!